Centocor Partners Neurochem to Gain Access to Amyloidosis Drug

By Business Review Editor

Pharma Deals Review: Vol 2005 Issue 56 (Table of Contents)

Published: 5 Feb-2005

DOI: 10.3833/pdr.v2005.i56.725     ISSN: 1756-7874

Section: Licensing



Centocor entered into a collaboration and distribution agreement with Neurochem to gain access to Fibrillex™ (1,3-propanedisulfonate), indicated for the treatment of AA amyloidosis...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details